Try our Advanced Search for more refined results
Merck & Co. Inc.
-
Motion | Filed: May 03, 2024 | Entered: May 03, 2024 Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Stipulation to EXTEND Time
STIPULATION TO EXTEND TIME see stipulation for details to - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra)
-
Motion | Filed: May 03, 2024 | Entered: May 03, 2024 Merck Sharp & Dohme LLC v. The Johns Hopkins University
Patent | Maryland
Pro Hac Vice - Corrected
CORRECTED MOTION to Appear Pro Hac Vice for Dana R. Weir by Merck Sharp & Dohme LLC. The fee has already been paid.(Manley, Kwame)
-
Motion | Filed: May 03, 2024 | Entered: May 03, 2024 Merck Sharp & Dohme LLC v. The Johns Hopkins University
Patent | Maryland
Pro Hac Vice - Corrected
CORRECTED MOTION to Appear Pro Hac Vice for Elizabeth Moore by Merck Sharp & Dohme LLC. The fee has already been paid.(Manley, Kwame)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login